Quantum量子訊息有限公司

AI Prior Authorization Market

完整報告名稱與涵蓋範圍
AI Prior Authorization Market Size, Share & Trends Analysis Report, By Solution Type (Provider-Side Prior Authorization Automation, Payer-Side Utilization Management and Clinical Review AI, Electronic Prior Authorization Networks and Clearinghouses, Pharmacy and Specialty Medication Authorization Solutions), By Deployment (Cloud-Based, EHR and Payer System Integrated), By End User (Hospitals, Health Systems and Physician Groups, Health Plans and Payers, Pharmacies, Pharmacy Benefit Managers and Specialty Pharmacies), By Region, and Segment Forecasts, 2026-2035

報告摘要

The AI prior authorization market covers provider-side automation that identifies requirements, assembles documentation and submits requests, payer-side utilization management and clinical review AI, electronic prior authorization networks and clearinghouses and pharmacy and specialty medication authorization solutions, deployed through cloud platforms integrated with electronic health records and payer systems. Manual prior authorization outsourcing services without automation and general revenue cycle management software are excluded. The category is being propelled by regulation that requires payers to adopt electronic prior authorization interfaces and decision timeframes, by provider frustration with administrative burden and care delays and by payer commitments to reduce authorization volumes and speed approvals. AI extracts clinical evidence from records, matches it to medical policy, drafts requests and appeals and, on the payer side, automates approvals for straightforward cases while routing complex ones to clinicians, with several states and federal rules now constraining fully automated denials. Vendors compete on payer connectivity, policy coverage, integration with electronic health records, accuracy and auditability, and the market is consolidating as clearinghouses, health record vendors and payer-owned technology arms acquire specialists. North America dominates given the prevalence of prior authorization in the United States, with limited but growing adoption in private insurance markets in Europe, the Middle East and Asia. Competition involves clearinghouses and interoperability networks, payer-affiliated technology groups, electronic health record vendors and AI start-ups serving providers and payers. The InsightAce study supplies US$ forecasts for all solution type, deployment and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global AI Prior Authorization Market Snapshot Chapter 4. Global AI Prior Authorization Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Solution Type Estimates & Trend Analysis 5.1. Solution Type & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Solution Type: 5.2.1. Provider-Side Prior Authorization Automation 5.2.2. Payer-Side Utilization Management and Clinical Review AI 5.2.3. Electronic Prior Authorization Networks and Clearinghouses 5.2.4. Pharmacy and Specialty Medication Authorization Solutions Chapter 6. Market Segmentation 2: By Deployment Estimates & Trend Analysis 6.1. Deployment & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment: 6.2.1. Cloud-Based 6.2.2. EHR and Payer System Integrated Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis 7.1. End User & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 7.2.1. Hospitals, Health Systems and Physician Groups 7.2.2. Health Plans and Payers 7.2.3. Pharmacies, Pharmacy Benefit Managers and Specialty Pharmacies Chapter 8. AI Prior Authorization Market: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. United States 8.1.2. Canada 8.2. Europe 8.2.1. Germany 8.2.2. United Kingdom 8.2.3. France 8.2.4. Italy 8.2.5. Spain 8.2.6. Rest of Europe 8.3. Asia Pacific 8.3.1. China 8.3.2. Japan 8.3.3. India 8.3.4. South Korea 8.3.5. Australia 8.3.6. Southeast Asia 8.3.7. Rest of Asia Pacific 8.4. Latin America 8.4.1. Brazil 8.4.2. Mexico 8.4.3. Rest of Latin America 8.5. Middle East & Africa 8.5.1. GCC Countries 8.5.2. South Africa 8.5.3. Rest of Middle East & Africa Chapter 9. Competitive Landscape 9.1. Company Market Positioning Analysis 9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 10. Company Profiles 10.1. Availity, LLC 10.2. Cohere Health, Inc. 10.3. Optum (UnitedHealth Group) 10.4. Waystar Holding Corp. 10.5. Rhyme (PriorAuthNow) 10.6. Infinitus Systems, Inc. 10.7. Anterior 10.8. Latent Health 10.9. Epic Systems Corporation (Payer Platform) 10.10. Surescripts, LLC 10.11. CoverMyMeds (McKesson Corporation) 10.12. Experian Health 10.13. Olive AI Legacy Platforms 10.14. Change Healthcare (Optum) 10.15. Myndshft Technologies, Inc.

圖表清單 List of Tables & Figures

Table 1. Global AI Prior Authorization Market Revenue Forecast by Solution Type, 2026-2035 (US$ Mn) Figure 1. Global AI Prior Authorization Market Segmentation Overview Table 2. Global AI Prior Authorization Market Revenue Forecast by Deployment, 2026-2035 (US$ Mn) Figure 2. Global AI Prior Authorization Market Share by Solution Type, 2026 & 2035 Table 3. Global AI Prior Authorization Market Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 3. Prior Authorization Workflow Automation Across Provider, Network and Payer Layers Table 4. North America AI Prior Authorization Market Revenue by Country, 2026-2035 (US$ Mn) Figure 4. Global AI Prior Authorization Market Share by Deployment, 2026 & 2035 Table 5. Europe AI Prior Authorization Market Revenue by Country, 2026-2035 (US$ Mn) Figure 5. Regulatory Requirements for Electronic Prior Authorization and Decision Timeframes, 2025-2027 Table 6. Asia Pacific AI Prior Authorization Market Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Asia Pacific AI Prior Authorization Growth Opportunity Analysis Table 7. Latin America AI Prior Authorization Market Revenue by Country, 2026-2035 (US$ Mn) Figure 7. Authorization Volume, Turnaround and Denial Rate Impacts of AI Adoption Table 8. Middle East & Africa AI Prior Authorization Market Revenue by Country, 2026-2035 (US$ Mn) Figure 8. Competitive Positioning of Key AI Prior Authorization Market Participants

提及公司

Availity, LLCCohere Health, Inc.Optum (UnitedHealth Group)Waystar Holding Corp.Rhyme (PriorAuthNow)Infinitus Systems, Inc.AnteriorLatent HealthEpic Systems Corporation (Payer Platform)Surescripts, LLCCoverMyMeds (McKesson Corporation)Experian HealthOlive AI Legacy PlatformsChange Healthcare (Optum)Myndshft Technologies, Inc.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們